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Introduction
Bupivacaine is a local anesthetic compound belonging to the 
amino amide group. Its anesthetic effect is commonly related to 
its inhibitory effect on voltage-gated sodium channels, which are 
blocked in the inactivated state.1,2 However, several studies have 
shown that this drug can also inhibit K+ channels by a differ-
ent blocking mechanism. Voltage dependent K+ channels, such 
as K
v
1.1, KCNQ2/Q3 and HERG,3 K
ATP
 channels and K
2P
 chan-
nels are blocked by bupivacaine in different types of cells.4,5 In 
the cases where the inhibitory mechanism of K+ channels was 
investigated, bupivacaine produced a characteristic open channel 
block.6 The blocking of K+ channels could explain the observed 
effects of bupivacaine on blood vessels. In particular, bupivacaine 
produced contraction of rat muscle arterioles7 and of isolated 
human umbilical artery (HUA) rings.8,9 Additionally, Rossner 
et al.10 demonstrated that bupivacaine depolarized and increased 
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intracellular Ca2+ of cultured smooth muscle cells obtained from 
HUA.
Up to now, there are no reports of bupivacaine effects on 
large conductance voltage- and Ca2+-activated K+ channels 
(BK
Ca
). This channel is highly expressed in vascular smooth 
muscle cells and is functionally relevant being involved in the 
control of contractile properties in most blood vessels. In this 
study we demonstrate that bupivacaine can inhibit BK
Ca
 in 
vascular smooth muscle cells isolated from HUA. Our results 
show that bupivacaine blocks BK
Ca
 channel by inducing a 
reduction of its conductance, and a flickery mode of the open 
channel state. These results show a new effect of bupivacaine 
on a kind of channel highly expressed in HUA smooth muscle 
cells. Since umbilical arteries are important for the regulation 
of feto-placental blood flow, the demonstration that bupiva-
caine affects K+ channels in this human artery is physiologi-
cally relevant.
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In presence of 1.2 μM Ca2+, where the BK
Ca
 channel has a 
high level of activity, bupivacaine (300 μM) produced a decrease 
in the amplitude of single-channel current and a flickery mode 
of the open channel state (Fig. S2). To further study the dose-
dependence of the blocking effect of this local anesthetic we 
recorded the channel activity at +60 mV using a solution with 
low Ca2+ concentration in contact with the intracellular face of 
the membrane patch, so the channel displayed an adequate (not 
too high) level of activity. Figure 1A shows typical recordings 
with a single channel opening obtained in control condition, 
in the presence of 30, 100, 300 and 1,000 μM of bupivacaine 
in the BS, and after drug washout. It is possible to observe that 
Results
The BK
Ca
 channel is one of the K+ channels frequently observed 
in inside-out patches obtained from human umbilical artery 
smooth muscle cells, as we described in a previous study.11 Figure 
S1 shows typical results which characterize this channel: increase 
of open probability (NPo) by augmenting free-Ca2+ concentration 
to 1.2 μM (Fig. S1A), high selectivity to K+ (P
K
/P
choline
 > 15.77 
and P
K
/P
Cs
 > 15.77) (Fig. S1B), voltage- and Ca2+-dependence 
of NPo (Fig. S1C), a single channel conductance of 234 ± 63 pS 
(Fig. S1D), and complete blockage by 500 nM paxilline (a selec-
tive blocker of BK
Ca
 channels) (Fig. S1E).
Figure 1. Concentration- and voltage-dependent block of BKCa channel produced by bupivacaine. (A) Typical recordings of a single channel open 
event in an IO patch clamped at +60 mV. The parts show the effects of increasing concentrations of bupivacaine on BKCa channel open state. All 
records come from the same patch and represent 250 ms of channel recording chosen so that the amounts of time spent in the open and closed states 
were approximately equal. (B) All-point current amplitude histograms (0.2 pA bin width) corresponding to the recordings shown in (A). The closed and 
open levels are indicated as C and O, respectively. (C) Mean values of open channel current amplitude (μo - μc) obtained from the fitting of 5–12 sets 
of histograms equivalent to those shown in (B) (each set comes from a different patch). The symbol * and the symbol #indicate statistically significant 
difference vs. control conditions and vs. 300 μM bupivacaine, respectively, by ANOVA followed by Holm-Sidak test (p < 0.05). (D) Mean values of open 
channel current amplitude standard deviation (σo) obtained from the fitting of the same sets of histograms as in (C). The symbol * and the symbol 
#indicate statistically significant difference vs. control conditions and vs. 100 μM bupivacaine, respectively, by ANOVA followed by Holm-Sidak test 
(p < 0.05). (E) Blocked current values (iB) normalized to the current without block (ic) plotted vs. the logarithm of bupivacaine concentration for 3–9 
IO patches clamped at different membrane potentials. The data were well fitted with a sigmoid function (see Results) from which the bupivacaine 
dissociation constant from the channel (KD) for each membrane potential can be obtained. (F) Plot of the KD values calculated in (E) as a function of 
the membrane potential. This relationship was well-fitted by an exponential decay function (see Results) from which one can obtain the location of 
the bupivacaine blocking site in the channel (δ) in terms of the fraction of the electrical field (the electrical distance) measured from the inside of the 
membrane.
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that the blocking effect of bupivacaine is voltage dependent, that 
depolarization increases the drug affinity, and that the binding 
site for bupivacaine is located at ~46% of the way along the mem-
brane field.
Another parameter that could have been analyzed was the 
NPo value of BK
Ca
 channel as a function of bupivacaine concen-
tration. However, because of bupivacaine-induced flickery mode 
of block, it was not possible to measure it precisely. The NPo 
value obtained from the area of the all-point histograms would 
have underestimated this parameter, while the value obtained 
from the idealized recording from single channel events detec-
tion by the half-amplitude threshold criterion would have over-
estimated it.
In order to test if the flickery block mode and the reduction in 
single channel current amplitude was enough to induce inhibi-
tion of macroscopic current we performed a series of experiments 
where the current was recorded in whole-cell configuration. The 
effect of bupivacaine was tested on a family of currents evoked 
by 500 ms voltage steps between -70 and +60 mV from a holding 
potential of -50 mV. In our experimental conditions (see whole-
solutions in Methods), about 85% of the total control current 
was carried by BK
Ca
 channels, as judged by sensitivity to 500 nM 
paxilline (Fig. 2C and D). Increasing the paxilline concentration 
did not augment the blocking effect (data not shown). The mac-
roscopic current was partially blocked by superfusion with 300 
μM bupivacaine (Fig. 2A) and this effect was completely revers-
ible (Fig. 2A–C) after 3 min of washing. Figure 2B shows the 
mean current-voltage relationships (I–V) of the steady-state cur-
rent in control conditions, after the stable effect of bupivacaine 
and after washout. Subsequent to the current recovery, the same 
cell was superfused with a solution containing 500 nM paxilline 
and, after stabilization, paxilline plus bupivacaine to compare the 
effects of both drugs. While paxilline blocked whole-cell current 
almost completely, bupivacaine inhibited 44% of control current, 
and the effect of the two drugs applied together was not different 
from the effect of paxilline alone (Fig. 2C and D).
Discussion
The results presented in this study show that the local anesthetic 
bupivacaine inhibits BK
Ca
 channels in HUA smooth muscle cells. 
This was demonstrated both at the single-channel level, as well as 
on whole-cell K+ currents. Up to now, there have been no reports 
in the literature about the effects of bupivacaine on BK
Ca
 chan-
nels. This channel is highly expressed in vascular smooth muscle 
cells and is functionally relevant, being involved in the control of 
contractile properties in most blood vessels.
In the single-channel configuration the ionic selectivity analy-
sis, the voltage and paxilline sensitivity, the conductance value, 
and the increase in open probability when the intracellular Ca2+ 
concentration was elevated, all indicate that the channel blocked 
by bupivacaine is the BK
Ca
 channel. This drug is able to block 
the BK
Ca
 channel both during its activation by low micromolar 
free Ca2+ and in the presence of a modest intracellular Ca2+ con-
centration, where the open probability was lower. In this latter 
condition, the analysis of the blocking effect was investigated 
bupivacaine, in a concentration-dependent manner, produced a 
reduction of single-channel BK
Ca
 current amplitude and induced 
a clear flickery mode of the open channel state observed as an 
increase in the noise of the open channel level. To quantify the 
reduction in current amplitude we obtained the mean amplitude 
of the control and of the flickery-blocked channel from the all-
point histogram distributions from 250 ms of a single channel 
recording as described in Methods (Fig. 1B). The histograms 
were fitted with a Gaussian function with two components 
obtaining the mean current amplitudes of the open and closed 
state (μ
o
 and μ
c
, respectively), together with the standard devia-
tion (σ
o
) of the open peak, which can be taken as a measure of 
bupivacaine-induced current flicker. Mean values for single chan-
nel current amplitude (μ = μ
o
 - μ
c
) and σ
o
 as function of bupi-
vacaine concentration are depicted in Figure 1C and D, where 
it can be seen that as bupivacaine concentration rose, the cur-
rent amplitude (μ) significantly diminished, while the noise (σ
o
) 
increased. These effects were completely reversible after washout 
(Fig. 1C and D). The effect of bupivacaine was quick, both in 
its onset and in the reversal of its block after washout. After 30 
sec of perfusion bupivacaine effect was already stable, while it 
disappeared completely after 1 min of washout. The reduction 
effect in the single channel open current amplitude as a function 
of time is shown in Figure S3.
To explore the voltage-dependence of bupivacaine BK
Ca
 chan-
nel block, the mean amplitude of BK
Ca
 single-channel currents 
were measured at each bupivacaine concentration and at differ-
ent membrane potentials. The blocked current values (i
B
) were 
normalized to the current without block (i
c
) and this relation-
ship (i
B
/i
c
) plotted vs. the logarithm of bupivacaine concentration 
(Fig. 1E); the resulting data points were fitted with the following 
equation:
where x is the logarithm of bupivacaine concentration and h is 
the Hill slope.12,13 From this equation, one can obtain the drug 
dissociation constant (K
D
) which represents the bupivacaine con-
centration that produces 50% current inhibition (IC
50
) at each 
membrane potential. The K
D
 calculated for different membrane 
potentials were statistically different and Figure 1F shows these 
values plotted as a function of the membrane potential. This rela-
tionship was well-fitted by an exponential decay function:12,13
where K
D
 (0) is the K
D
 value at 0 mV, z is the valence of the 
blocker (+1 in this case), V is the voltage across the membrane, 
δ is the location of the blocking site in terms of the fraction of 
the electrical field (the electrical distance) measured from the 
inside of the membrane, and RT/f = 25.3 mV at 22°C. A K
D
(0) 
of 1,444 μM and a δ of 0.46 were obtained from the best fit to 
the graph shown in Figure 1F. Together, these results suggest 
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depolarizing step, as the current in presence of bupivacaine had 
lower amplitude than in control conditions but maintained the 
kinetics of activation for each voltage pulse. Since the combina-
tion of bupivacaine plus paxilline did not produce an additive 
block, we can conclude that 300 μM bupivacaine partially blocks 
the BK
Ca
 macroscopic current in accordance with the single-
channel results. The effect of bupivacaine on this channel shows 
that this drug presents different blocking mechanisms depending 
on the type of ionic channel involved; e.g., Nilsson et al. reported 
an open channel block mode for two types of K
V
 channels.
Regarding the drug accessibility to the channel, the analy-
sis of unitary currents suggests that the site of action is located 
on the internal side of the channel. Moreover, as bupivacaine 
is a molecule that can readily cross the plasma membrane, one 
could expect it to be effective on BK
Ca
 channels when applied 
on either side of the membrane. This idea is consistent with our 
data obtained from whole-cell and inside-out patch recording 
configurations, as we observed that bupivacaine is able to readily 
block the channel when applied to either the external or internal 
side of the plasma membrane.
BK
Ca
 channels are widely expressed and involved in differ-
ent and relevant physiological functions in different types of 
in more detail. In IO patches, bupivacaine quickly induced a 
flickering open channel behavior observed as an increase in the 
noise of the open channel level (estimated by σ
o
) and a clear and 
significant concentration-dependent reduction of single-channel 
current amplitude. All these effects were reversible following 
washout of bupivacaine from the bath. We also observed that 
bupivacaine blocking effect was voltage-dependent, since the 
drug K
D
 changed e-fold per 54.7 mV (decreasing with depolar-
ization), indicating that the drug binding is affected by the mem-
brane electrical field, probably by facilitating its entrance into the 
pore region of the channel. The calculated value of the electrical 
distance of block suggests that the binding site for this drug is 
located at ~46% of the way along the membrane field, measured 
from the inside of the membrane. These results can be compared 
with those reported for intracellular effects of other BK
Ca
 channel 
blockers, such as TEA and Cs+.14
Bupivacaine can also block whole-cell K+ currents in which, 
under our working conditions, BK
Ca
 is a main component. Time-
dependent block by bupivacaine has been reported for some 
subtypes of K
V
 channels, suggesting that bupivacaine has a selec-
tive affinity for the open channel state.6 In our case, 300 μM of 
bupivacaine did not induce any time-dependent block during the 
Figure 2. Bupivacaine inhibits a BKCa component of whole-cell K
+ currents in HUA smooth muscle cells. (A) Superimposed representative recordings 
of whole-cell currents obtained by applying 10 mV voltage steps from -70 mV to +60 mV from a holding potential of -50 mV in control conditions (left 
part), after 300 μM bupivacaine (middle part) and after bupivacaine washout (right part). (B) Mean IV curves obtained in the same conditions as in (A) 
(n = 10). The symbol *indicates statistically significant difference from control (Student’s t test, p < 0.05). (C) superimposed representative recordings of 
currents evoked by single steps to +40 mV from a holding potential of -50 mV obtained in a cell which was exposed sequentially to control conditions, 
then to 300 μM bupivacaine, to washout of bupivacaine followed by 500 nM paxilline and finally, 300 μM bupivacaine plus 500 nM paxilline. (D) Mean 
± SEM values for the protocol shown in (C) (n = 3–10). The symbol * and the symbol #indicate statistically significant difference vs. control conditions 
and vs. 300 μM bupivacaine, respectively, by ANOVA followed by Holm-Sidak test (p < 0.05).
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the treated tissue using a Pasteur pipette. The remaining tis-
sue and the supernatant containing isolated cells were stored 
at room temperature (~22°C) until used. HUA smooth muscle 
cells were allowed to settle onto the coverglass bottom of a 3 ml 
experimental chamber.
Patch-clamp current recordings. The isolated HUA smooth 
muscle cells were observed with a mechanically stabilized, 
inverted microscope (Telaval 3, Carl Zeiss, Jena) equipped with 
a 40x objective lens. Application of test solutions was performed 
through a multibarreled pipette positioned close to the cell inves-
tigated. After each experiment on a single cell, the experimental 
chamber was replaced by another one containing a new sample of 
cells. Only well-relaxed, spindle-shaped smooth muscle cells were 
used for electrophysiological recordings. Data were collected 
within 4–6 h after cell isolation. All experiments were performed 
at room temperature (~22°C).
The standard tight-seal inside-out and whole-cell configu-
rations of the patch-clamp technique24 were used to record 
single-channel and macroscopic currents respectively. Glass 
pipettes were drawn from WPI PG52165-4 glass on a two-stage 
vertical micropipette puller (PP-83, Narishige Scientific 
Instrument Laboratories) and pipette resistance ranged from 
2 to 4 MΩ.
Single-channel recordings. Single-channel currents were 
recorded in the inside-out configuration (IO), filtered with a 
4-pole lowpass Bessel filter at 2 kHz (Axopatch 200A ampli-
fier, Molecular Devices) and digitized (Digidata 1200 Axon 
Instruments) at 16 kHz. Voltage-clamp 30–60 sec record-
ings were obtained at different membrane potentials to 
obtain the single channel current amplitude and the open 
probability (NPo) of the channels. The control pipette solu-
tion (PS) used for single-channel recordings contained (in 
mM): 140 KCl, 0.5 MgCl
2
, 10 HEPES, 6 glucose, 1 CaCl
2
, 
5 4-aminopirydine (4-AP), pH adjusted to 7.4 with HCl. 4-AP 
was added to block K
v
 channels present is HUA smooth muscle 
cells.11 The bath solution (BS) in contact with the cytosolic face 
of the membrane contained (in mM): 140 KCl, 0.5 MgCl
2
, 10 
HEPES, 6 Glucose, 1 EGTA, pH adjusted to 7.4 with KOH. 
Different amounts of CaCl
2
 were added to the BS to obtain the 
desired free Ca2+ concentrations tested (1.2 μM or 3 nM; cal-
culated using Maxchelator software from Stanford University: 
maxchelator.stanford.edu).
In order to obtain the relative permeability of the channel to 
different cations, the BS was modified for some of the experi-
ments: KCl was totally replaced with either 140 mM of CsCl 
or with 140 mM choline chloride. In these cases, the free Ca2+ 
concentration was 1.2 μM, which provides adequate activ-
ity of BK
Ca
 channel over a wide range of membrane potentials. 
Different concentrations of bupivacaine (30, 100, 300 and 1,000 
μM) were added to the BS to study voltage- and concentration-
dependent effects of this drug on BK
Ca
 channels.
Single-channel currents were analyzed with the pCLAMP 
software (version 9.2). Current amplitude histograms were plot-
ted for each membrane potential tested to obtain a current-volt-
age relationship for the study of single channel properties. Open 
probability is expressed as NPo, where N is the number of single 
cells. Activation of these channels induced by an increase in 
the intracellular Ca2+ concentration produces hyperpolariza-
tion of the cell membrane, thereby diminishing membrane 
excitability. This is important for the regulation of different 
cell mechanisms, like contractility of smooth muscle cells15 or 
action potential frequency, duration, and inter-burst intervals 
in neurons.16 So, the inhibitory effect of bupivacaine on BK
Ca
 
channel activity could affect different physiological functions. 
In particular, our results give an explanation for the previously 
described bupivacaine effect on HUA rings, where Rossner et al. 
observed that this drug produced depolarization and contrac-
tion of this vessel.
In obstetrics bupivacaine is commonly used during labor and 
delivery. Placental transfer of this drug has been confirmed by 
the presence of measurable quantities of bupivacaine in umbili-
cal cord blood.17 Although there are several studies that indicate 
that bupivacaine use is safe for the mother and fetus,18-20 it has 
been shown in rats that a considerable amount of bupivacaine is 
taken up by both sides of the placenta, as well as the amnion and 
myometrium.21 Moreover, Monuszko et al. suggest that unin-
tentional intravascular injection of bupivacaine intended to be 
epidural may lead to plasma concentrations sufficiently high to 
cause umbilical vessel contraction with adverse fetal effects. Since 
BK
Ca
 channels are important for the regulation of human umbili-
cal artery tone, we think that the fact that bupivacaine blocks 
these channels in this human vessel should be taken into account 
when using this anesthetic.
In summary, this study presents a new inhibitory effect of 
bupivacaine on a K+ channel involved in several cell functions 
and particularly, highly expressed in vascular smooth muscle 
cells.
Methods
Umbilical cords were obtained from normal, term pregnan-
cies after vaginal and cesarean deliveries, placed in transport 
solution of the following composition (in mM): 130 NaCl, 
4.7 KCl, 1.17 KH
2
PO
4
, 1.16 MgSO
4
, 24 NaCO
3
H, 2.5 CaCl
2
, 
pH 7.4 at 4°C and immediately taken to our laboratory where 
they were stored at 4°C and used within the next 24 hs. All 
procedures are in accordance with the declaration of Helsinki 
(1975).
Cell isolation procedure for patch-clamp experiments. 
The HUA were dissected from the Wharton’s jelly just before 
the cell isolation procedure. HUA smooth muscle cells were 
obtained by a method based on the one described by Klockner 
et al. and later modified in our laboratory in order to dimin-
ish the enzyme content in the dissociation medium (DM).23 
Briefly, a segment of HUA was cleaned of any residual con-
nective tissue, cut in small strips, and placed for 15 min in a 
DM containing (in mM): 140 NaCl, 5 KH
2
PO
4
, 5 MgCl
2
, 6 
glucose, 5 HEPES; pH was adjusted to 7.4 with NaOH. The 
strips were then placed in DM with 2 mg/ml collagenase type I 
during 25 min, with gentle agitation, at 35°C. After the incuba-
tion period the strips were washed with DM and single HUA 
smooth muscle cells were obtained by a gentle dispersion of 
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curves. Fitting parameters, mean (μ) and standard deviation 
(σ), were used to analyze current amplitude (μ
open
 - μ
closed
) and 
open channel noise (σ
open
) in absence and presence of 30, 100, 
300 and 1,000 μM bupivacaine and after washout. Analysis 
of dose-response relationships at different membrane poten-
tials was performed using the sigmoidal dose-response (variable 
slope) curve fitting on GraphPad Prism 4.0. Voltage depen-
dence of K
D
 was fitted with a single exponential decay (Origin 
Pro 8 Software), in order to obtain δ (see Results for more 
details).
Whole-cell recordings. Whole-cell currents were filtered 
with a 4-pole lowpass Bessel filter (Axopatch 200A amplifier) 
at 2 kHz and digitized (Digidata 1200 Molecular Devices) at a 
sample frequency of 20 kHz. The experimental recordings were 
stored on a computer hard disk for later analysis. The pipette 
solution contained (in mM): 130 KCl, 10 HEPES, 0.1 EGTA, 
1 MgCl
2
, 0.1 CaCl
2
, 5 ATP-Na
2
; pH was adjusted to 7.4 with 
KOH giving a calculated free Ca2+ concentration of 0.7 μM. 
The bath solution contained (in mM): 130 NaCl, 5.4 KCl, 
1.2 MgCl
2
, 2.5 CaCl
2
, 5 HEPES, 6 glucose, 5 4-AP; pH was 
adjusted to 7.4 with HCl. Under these conditions K
ATP
 and Kv 
channels contribution to the macroscopic current are inhibited 
by ATP-Na
2
 and 4-AP, respectively,11 while the intracellular 
free Ca2+ concentration ensures a significant BK
Ca
-carried cur-
rent component. Whole-cell current stability was monitored by 
applying successive 500 ms voltage steps (from a holding poten-
tial of -50 mV to a test potential of +40 mV) discarding those 
cells in which the current amplitude did not remain constant in 
time. After the current was stable, this same voltage-clamp step 
protocol was applied in control or in the different experimental 
conditions (300 μM bupivacaine, 500 nM paxilline, or bupiva-
caine and paxilline together). A family of voltage steps between 
-70 and +60 mV from a holding potential of -50 mV were also 
applied in each stable condition for further current-voltage rela-
tionship (I–V) analysis. Cell membrane capacitance was calcu-
lated from the capacity current obtained from the recording of a 
single 10 mV hyperpolarizing step.
Drugs and reagents used. Bupivacaine hydrochloride, pax-
illine, 4-aminopyridine (4-AP), EGTA, Na
2
ATP, and all the 
enzymes used for cell isolation were purchased from Sigma 
Chemical Co. All other reagents were of analytical grade and 
purchased from local vendors. Bupivacaine was dissolved in dis-
tilled water. Paxilline was dissolved in DMSO. Fresh aliquots of 
stock solutions of paxilline and bupivacaine were added to the 
bath solution on the day of the experiment. When comparing 
with paxilline effects, an appropriate amount of DMSO was 
added to all solutions without paxilline.
Statistics. The results are expressed as mean ± standard error 
of the mean. Paired or unpaired Student’s t-tests were used to 
compare two groups. For the comparison of multiple groups, 
ANOVA followed by an appropriate test was used. In all cases, a 
p value lower than 0.05 was considered for establishing statisti-
cally significant differences.
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channels present in each patch. NPo values were calculated using 
the following expression:
where T is the duration of recording and t
j
 is the time spent with 
j = 1,2,3,…n channels open. The parameters were obtained from 
single channel events detection by the half-amplitude threshold 
criterion. Stationary conditions of single channel recordings were 
controlled by plotting the NPo values calculated for intervals of 5 
sec during the 30 sec of recording as function of time. The NPo 
values in control conditions were stable during the recording time 
in all studied patches.
The K+ selectivity of the channel was tested by studying the 
relative permeabilities of Cs+ and choline to K+ under conditions 
of zero net current. These were estimated by analyzing the shift 
in the reversal potential under biionic conditions.25 The rela-
tionship between the permeability ratio and the shift in reversal 
potential was obtained from the Goldman-Hodgkin-Katz equa-
tion.26,27 If K+ in contact with the inner surface of the membrane 
is replaced equimolarly by X+ while not altering the K+ concentra-
tion in contact with the outward membrane surface, the shift in 
reversal potential is given by:
where V
x
 and V
K
 are the reversal potentials with X+ and K+ at the 
inner membrane surface, respectively; P
x
 and P
k
 are the perme-
abilities of the channel to X+ and K+, respectively; K
o
, K
i
; and X
i
 
are the concentrations of the indicated ions; and F/RT = 0.0394 
mV-1 at 22°C. The permeability ratio of X+ to K+ is then obtained 
by rearrangement:
For the selectivity experiments presented in this paper, K
o
 and 
K
i
 were both 140 mM, so that V
K
 = 0. Data for determining 
reversal potentials were obtained by plots of single channel cur-
rent amplitude vs. membrane potential, which were nonlinear 
for the ions studied.28 In the experiments where reversal of the 
currents was not observed at the range of membrane potential 
tested, “reversal potentials” are reported as greater than the high-
est membrane potential tested.
Because bupivacaine decreased single channel current ampli-
tude and increased the open channel noise (see results), the 
voltage- and dose-dependent blocking effect of bupivacaine on 
BK
Ca
 channel was analyzed on all-points amplitude histograms 
obtained from portions of single channel recordings of 250 ms 
of length chosen so the open channel time was the same as the 
closed channel time. A nonlinear Levenberg-Marquardt least 
squares curve fitting procedure was used for fitting Gaussian 
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